Sherpa Clinical Packaging continues to invest in growth and infrastructure with its latest facility addition. The facility expansion will support continued growth in Sherpa’s packaging, labeling, and distribution services, especially as it relates to later stage projects and global studies, the company said. The new building will house four packaging suites, a class 100,000 cleanroom, and various temperature-controlled storage areas including expansive 2-8°C and -20°C rooms, and a Controlled Room Temperature warehouse. The new cGMP facility consists of 24,000 square-feet and is adjacent to Sherpa’s existing 38,000 square-foot headquarters.

“I am extremely pleased to see so many of our customers moving into Phase II and III clinical trials,” said Mark Paiz, president and founder, Sherpa. “As the number of global clinical trials that Sherpa supports increases over the next few years, Sherpa’s expanded clinical supply offerings, partnerships and facilities are well poised to support this growth.”

Construction of the building has commenced and is expected to be completed by July 2017. In addition to facilities expansion, Sherpa says it plans to add significantly to its operations, quality, and project management teams within the next year.